Comments
Strides Vivimed Pte Ltd, Singapore, a 50:50 joint venture with Vivimed Labs, has received approval from the United States Food & Drug Administration for Albendazole tablets in the strength of 200 mg.
According to a BSE filing, Albendazole tablets are used in the treatment of certain infections caused by tapeworm. This is the second generic approval by USFDA for Albendazole tablets.
Strides Pharma Science said the approved product is a generic version of Amneal Pharmaceuticals Inc’s Albenza tablets. Quoting IQVIA MAT data, Strides Pharma Science said the US market for Albendazole tablets USP 200 mg is approximately $100 million.
Shares of Strides Pharma Science were trading 1.22 per cent higher at Rs 436 apiece on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.